Todd Lorenz

MD – Consulting Chief Medical Officer


Todd is an experienced clinical development professional with 15 years in upper management positions at Johnson & Johnson, Cor Therapeutics, Orexigen, Catalyst Biosciences and Corgentech. Also, as SVP, Clinical Development and Scientific Licensing at Portola Pharmaceuticals, Todd held primary responsibility for the Phase 3 program of betrixaban, involving 500 sites in 30 countries. Todd is also an advisor to the Stanford SPARK program and holds a BA in Chemistry from Case Western Reserve University and an MD from Case Western Reserve University, School of Medicine.

Please reload

© 2020 Peptilogics  I  All Rights Reserved